Dasatinib in Treating Patients With Advanced Liver Cancer That Cannot Be Removed by Surgery

Clinical trial NCT00459108 · TERMINATED

Trial details

NCT number: NCT00459108
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Adult Primary Hepatocellular Carcinoma Advanced Adult Primary Liver Cancer Recurrent Adult Primary Liver Cancer

Start date: 2007-04-01
Primary completion: 2011-04-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.